Ingevity Analyst Ratings
Ingevity Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/07/2023 | 3.16% | BMO Capital | $71 → $60 | Downgrades | Outperform → Market Perform |
07/27/2023 | — | Loop Capital | Upgrades | Hold → Buy | |
05/23/2023 | -5.43% | Wells Fargo | $66 → $55 | Maintains | Equal-Weight |
05/09/2023 | 37.55% | BMO Capital | $100 → $80 | Maintains | Outperform |
05/05/2023 | 13.48% | Wells Fargo | $80 → $66 | Maintains | Equal-Weight |
05/05/2023 | 10.04% | Loop Capital | $92 → $64 | Downgrades | Buy → Hold |
04/17/2023 | 37.55% | Wells Fargo | $85 → $80 | Maintains | Equal-Weight |
03/24/2023 | 58.18% | Loop Capital | $100 → $92 | Maintains | Buy |
03/01/2023 | 46.15% | Wells Fargo | $76 → $85 | Maintains | Equal-Weight |
02/02/2023 | 71.94% | Loop Capital | $81 → $100 | Upgrades | Hold → Buy |
01/09/2023 | 30.67% | Wells Fargo | $73 → $76 | Maintains | Equal-Weight |
11/04/2022 | 25.52% | Wells Fargo | $67 → $73 | Maintains | Equal-Weight |
10/18/2022 | 15.2% | Wells Fargo | $74 → $67 | Maintains | Equal-Weight |
10/11/2022 | 49.59% | BMO Capital | $89 → $87 | Maintains | Outperform |
05/09/2022 | 27.24% | Wells Fargo | $70 → $74 | Maintains | Equal-Weight |
10/29/2021 | 44.43% | Wells Fargo | $82 → $84 | Maintains | Equal-Weight |
07/29/2021 | 63.34% | Oppenheimer | $85 → $95 | Maintains | Outperform |
05/04/2021 | 89.13% | BMO Capital | $100 → $110 | Maintains | Outperform |
08/06/2020 | 44.43% | BMO Capital | $79 → $84 | Maintains | Outperform |
07/31/2020 | 13.48% | Stifel | $55 → $66 | Upgrades | Hold → Buy |
05/01/2020 | -5.43% | Wells Fargo | $43 → $55 | Maintains | Equal-Weight |
04/30/2020 | 11.76% | Oppenheimer | $80 → $65 | Maintains | Outperform |
04/03/2020 | -26.07% | Wells Fargo | → $43 | Downgrades | Overweight → Equal-Weight |
03/24/2020 | -27.79% | Stifel | $67 → $42 | Maintains | Hold |
02/21/2020 | 15.2% | Stifel | $76 → $67 | Maintains | Hold |
01/24/2020 | — | Loop Capital | Upgrades | Hold → Buy | |
12/06/2019 | 65.06% | Loop Capital | → $96 | Downgrades | Buy → Hold |
10/16/2019 | 71.94% | Wells Fargo | → $100 | Initiates Coverage On | → Outperform |
09/27/2019 | 118.36% | BMO Capital | $131 → $127 | Maintains | Outperform |
09/25/2019 | 70.22% | Stifel | $109 → $99 | Maintains | Hold |
09/05/2019 | — | Loop Capital | Upgrades | Hold → Buy | |
07/19/2019 | 83.98% | Jefferies | $129 → $107 | Downgrades | Buy → Hold |
07/18/2019 | — | BMO Capital | Initiates Coverage On | → Outperform | |
05/28/2019 | — | Berenberg | Upgrades | Hold → Buy | |
05/28/2019 | 89.13% | Berenberg | $120 → $110 | Upgrades | Hold → Buy |
04/08/2019 | 123.52% | Oppenheimer | $110 → $130 | Maintains | Outperform |
12/11/2018 | 44.43% | Stifel | → $84 | Initiates Coverage On | → Hold |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
08/07/2023 | 3.16% | 蒙特利爾銀行資本 | $71→$60 | 評級下調 | 跑贏→市場表現 |
07/27/2023 | - | 環路資本 | 升級 | 持有→購買 | |
2023年05月23日 | -5.43% | 富國銀行 | $66→$55 | 維護 | 等重 |
05/09/2023 | 37.55% | 蒙特利爾銀行資本 | $100→$80 | 維護 | 跑贏大盤 |
05/05/2023 | 13.48% | 富國銀行 | $80→$66 | 維護 | 等重 |
05/05/2023 | 10.04% | 環路資本 | $92→$64 | 評級下調 | 購買→Hold |
04/17/2023 | 37.55% | 富國銀行 | $85→$80 | 維護 | 等重 |
03/24/2023 | 58.18% | 環路資本 | $100→$92 | 維護 | 買 |
03/01/2023 | 46.15% | 富國銀行 | $76→$85 | 維護 | 等重 |
02/02/2023 | 71.94% | 環路資本 | $81→$100 | 升級 | 持有→購買 |
01/09/2023 | 30.67% | 富國銀行 | $73→$76 | 維護 | 等重 |
11/04/2022 | 25.52% | 富國銀行 | $67→$73 | 維護 | 等重 |
10/18/2022 | 15.2% | 富國銀行 | $74→$67 | 維護 | 等重 |
2022年10月11日 | 49.59% | 蒙特利爾銀行資本 | $89→$87 | 維護 | 跑贏大盤 |
05/09/2022 | 27.24% | 富國銀行 | $70→$74 | 維護 | 等重 |
10/29/2021 | 44.43% | 富國銀行 | $82→$84 | 維護 | 等重 |
07/29/2021 | 63.34% | 奧本海默 | $85→$95 | 維護 | 跑贏大盤 |
05/04/2021 | 89.13% | 蒙特利爾銀行資本 | $100→$110 | 維護 | 跑贏大盤 |
08/06/2020 | 44.43% | 蒙特利爾銀行資本 | $79→$84 | 維護 | 跑贏大盤 |
07/31/2020 | 13.48% | Stifel | $55→$66 | 升級 | 持有→購買 |
05/01/2020 | -5.43% | 富國銀行 | $43→$55 | 維護 | 等重 |
04/30/2020 | 11.76% | 奧本海默 | $80→$65 | 維護 | 跑贏大盤 |
04/03/2020 | -26.07% | 富國銀行 | →$43 | 評級下調 | 超重→等重 |
03/24/2020 | -27.79% | Stifel | $67→$42 | 維護 | 保持 |
02/21/2020 | 15.2% | Stifel | $76→$67 | 維護 | 保持 |
1/24/2020 | - | 環路資本 | 升級 | 持有→購買 | |
2019年6月12日 | 65.06% | 環路資本 | →$96 | 評級下調 | 購買→Hold |
2019年10月16日 | 71.94% | 富國銀行 | →$100 | 開始承保 | →跑贏大盤 |
2019年09月27日 | 118.36% | 蒙特利爾銀行資本 | $131→$127 | 維護 | 跑贏大盤 |
2019年09月25日 | 70.22% | Stifel | $109→$99 | 維護 | 保持 |
2019年05月09日 | - | 環路資本 | 升級 | 持有→購買 | |
2019年07月19日 | 83.98% | 傑富瑞 | $129→$107 | 評級下調 | 購買→Hold |
2019年07月18日 | - | 蒙特利爾銀行資本 | 開始承保 | →跑贏大盤 | |
2019年05月28日 | - | 貝倫伯格 | 升級 | 持有→購買 | |
2019年05月28日 | 89.13% | 貝倫伯格 | $120→$110 | 升級 | 持有→購買 |
2019年08月04日 | 123.52% | 奧本海默 | $110→$130 | 維護 | 跑贏大盤 |
2018年12月11日 | 44.43% | Stifel | →$84 | 開始承保 | →保留 |
What is the target price for Ingevity (NGVT)?
英傑華(Ingevity)的目標價是多少?
The latest price target for Ingevity (NYSE: NGVT) was reported by BMO Capital on August 7, 2023. The analyst firm set a price target for $60.00 expecting NGVT to rise to within 12 months (a possible 3.16% upside). 14 analyst firms have reported ratings in the last year.
BMO Capital於2023年8月7日報道了Ingevity(紐約證券交易所代碼:NGVT)的最新目標價。這家分析公司將目標價定為60.00美元,預計NGVT將在12個月內升至(可能上漲3.16%)。過去一年,有14家分析公司公佈了評級。
What is the most recent analyst rating for Ingevity (NGVT)?
Ingevity(NGVT)的最新分析師評級是多少?
The latest analyst rating for Ingevity (NYSE: NGVT) was provided by BMO Capital, and Ingevity downgraded their market perform rating.
BMO Capital提供了對Ingevity(紐約證券交易所代碼:NGVT)的最新分析師評級,Ingevity下調了他們的市場表現評級。
When is the next analyst rating going to be posted or updated for Ingevity (NGVT)?
Ingevity(NGVT)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingevity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingevity was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Ingevity的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Ingevity的上一次評級是在2023年8月7日提交的,所以你應該預計下一次評級將在2024年8月7日左右提供。
Is the Analyst Rating Ingevity (NGVT) correct?
分析師評級Ingevity(NGVT)正確嗎?
While ratings are subjective and will change, the latest Ingevity (NGVT) rating was a downgraded with a price target of $71.00 to $60.00. The current price Ingevity (NGVT) is trading at is $58.16, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Ingevity(NGVT)評級被下調,目標價為71.00美元至60.00美元。英傑華(Ingevity)目前的股價為58.16美元,超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。